According to the announcement on the 28th May, this trial will begin by years end.........????
Patrys’ next clinical trial will be using a second generation proteosome
inhibitor (Kyprolis (Carfilzomib)) in combination with PAT-SM6. The planning for this trial and the
manufacturing of the required PAT-SM6 is currently underway and we expect to commence the trial
before the end of 2014.”
ONXY trial
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.37M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 5414724 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 2206958 | 6 |
View Market Depth
| Last trade - 12.32pm 17/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable